Skip to main content
Clinical Trials/NCT07554079
NCT07554079
Completed
Not Applicable

Standard Versus Short Course Prophylactic Antibiotic in Femur and Tibia Shaft Fractures Managed With Intramedullary Interlocking Nail: A Prospective Randomized Comparative Study Using the ASEPSIS Score

Kathmandu University School of Medical Sciences1 site in 1 country56 target enrollmentStarted: February 15, 2024Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
56
Locations
1
Primary Endpoint
Incidence of Wound Infection based on ASEPSIS score

Overview

Brief Summary

Long-bone fractures, particularly of femur and tibia, are common following fall injury and road traffic accidents.1,2 The standard treatment is "intramedullary nailing," where a metal rod is inserted into the center of the bone to hold it in place.3,4 However, surgical site infection (SSI) and fracture related infection (FRI) remain significant complications of nailing that delay healing and increase healthcare costs.5,6

To prevent these infections, doctors give patients antibiotics around the time of surgery. However, there is ongoing debate about how long these antibiotics should be continued. In many regions, patients receive antibiotics for several days, but recent evidence suggests that a shorter course may be just as effective and could reduce the risk of antibiotic resistance and side effects.

Study Question The goal of this study is to determine if a one-day (short) course of antibiotics is as effective as a three-day (standard) course in preventing infections after bone-nailing surgery.

Hypotheses Null Hypothesis (H0): There is no significant difference in the incidence of infection or short-term clinical outcomes between the one-day (short-course) and three-day (standard-course) antibiotic protocols.

Alternative Hypothesis (H1): There is a significant difference in the incidence of infection or short-term clinical outcomes between the one-day (short-course) and three-day (standard-course) antibiotic protocols.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients (≥18 years)
  • Diaphyseal fractures of the femur (AO 32) or tibia (AO 42), including closed injuries and Gustilo-Anderson type I open fractures, who were scheduled for intramedullary interlocking nailing

Exclusion Criteria

  • Polytrauma
  • Open fractures classified as Gustilo-Anderson type II or III
  • Procedures other than intramedullary nailing
  • Pregnancy
  • Comorbidities known to affect infection risk, such as diabetes mellitus, immunocompromised states, chronic steroid use, active skin or chest infections, or other conditions requiring alternative antibiotic regimens

Arms & Interventions

Standard Course Antibiotics

Active Comparator

Nine postoperative doses of cefuroxime 750 mg; each dose every eight hours for three days

Intervention: Standard Course Antibiotics (Drug)

Short Course Antibiotics

Experimental

Intervention: Short Course Antibiotics (Drug)

Outcomes

Primary Outcomes

Incidence of Wound Infection based on ASEPSIS score

Time Frame: From enrollment to the end of postoperative follow up at six week

The primary outcome is the rate of wound infection as categorized by the ASEPSIS scoring system. The ASEPSIS score is a validated tool that evaluates wound healing based on clinical criteria (Additional treatment, Serous discharge, Erythema, Purulent exudate, Separation of deep tissues, Isolation of bacteria, and Stay as inpatient). Satisfactory Healing: Score 0-10 Disturbance in Healing: Score 11-20 Infection: Score \>20 The primary comparison will be the proportion of patients in each group reaching the "Wound Infection" category.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Rohit Shrestha

Professo

Kathmandu University School of Medical Sciences

Study Sites (1)

Loading locations...

Similar Trials